Effectiveness and safety of a 10mg warfarin initiation nomogram in Asian population

Research output: Contribution to journalArticle

Abstract

Anticoagulant responses to warfarin vary among patients, based on genetic factors, diet, concomitant medications, and disease state. We evaluated the effectiveness and safety of a 10mg warfarin initiation nomogram in an Asian population. Retrospective cross-sectional audit studies were conducted from March 2009 to March 2010. The use of a 10mg-loading dose to initiate warfarin treatment resulted in 33(84.6%) patients attaining a therapeutic INR within four days (mean time, 2.6 days). There was no significant correlation between age, gender, race, and serum albumin for the time to reach a therapeutic INR. A significant correlation was noted for patient's baseline INR and time to reach a therapeutic INR (P<0.05). No significant differences were observed in time to reach a therapeutic INR in patients treated with specific class of concomitant drugs or patients with specific disease states. The overall incidence of over-anticoagulation was 35.9%; however, no bleeding episodes were encountered. In conclusion, the use of a 10mg warfarin nomogram was effective in rapidly achieving a therapeutic INR. However, the nomogram's safety is debatable owing to the high over-anticoagulation rate warfarin-administered patients. Caution is recommended in the initiation of warfarin treatment using the 10mg nomogram.

Original languageEnglish
Pages (from-to)927-932
Number of pages6
JournalPakistan Journal of Pharmaceutical Sciences
Volume28
Issue number3
Publication statusPublished - 1 May 2015

Fingerprint

Nomograms
Warfarin
International Normalized Ratio
Safety
Population
Therapeutics
Serum Albumin
Anticoagulants
Cross-Sectional Studies
Hemorrhage
Diet
Incidence
Pharmaceutical Preparations

Keywords

  • Anti-coagulation
  • Coagulation
  • INR
  • Nomogram
  • Warfarin

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

@article{ac4ee0929eeb4d2ab0baa50f8457df85,
title = "Effectiveness and safety of a 10mg warfarin initiation nomogram in Asian population",
abstract = "Anticoagulant responses to warfarin vary among patients, based on genetic factors, diet, concomitant medications, and disease state. We evaluated the effectiveness and safety of a 10mg warfarin initiation nomogram in an Asian population. Retrospective cross-sectional audit studies were conducted from March 2009 to March 2010. The use of a 10mg-loading dose to initiate warfarin treatment resulted in 33(84.6{\%}) patients attaining a therapeutic INR within four days (mean time, 2.6 days). There was no significant correlation between age, gender, race, and serum albumin for the time to reach a therapeutic INR. A significant correlation was noted for patient's baseline INR and time to reach a therapeutic INR (P<0.05). No significant differences were observed in time to reach a therapeutic INR in patients treated with specific class of concomitant drugs or patients with specific disease states. The overall incidence of over-anticoagulation was 35.9{\%}; however, no bleeding episodes were encountered. In conclusion, the use of a 10mg warfarin nomogram was effective in rapidly achieving a therapeutic INR. However, the nomogram's safety is debatable owing to the high over-anticoagulation rate warfarin-administered patients. Caution is recommended in the initiation of warfarin treatment using the 10mg nomogram.",
keywords = "Anti-coagulation, Coagulation, INR, Nomogram, Warfarin",
author = "Haarathi Chandriah and Endang, {Kumolosasi Msi} and Islahudin, {Farida Hanim} and {Makmor Bakry}, Mohd",
year = "2015",
month = "5",
day = "1",
language = "English",
volume = "28",
pages = "927--932",
journal = "Pakistan Journal of Pharmaceutical Sciences",
issn = "1011-601X",
publisher = "Pakistan Journal of Pharmaceutical Sciences",
number = "3",

}

TY - JOUR

T1 - Effectiveness and safety of a 10mg warfarin initiation nomogram in Asian population

AU - Chandriah, Haarathi

AU - Endang, Kumolosasi Msi

AU - Islahudin, Farida Hanim

AU - Makmor Bakry, Mohd

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Anticoagulant responses to warfarin vary among patients, based on genetic factors, diet, concomitant medications, and disease state. We evaluated the effectiveness and safety of a 10mg warfarin initiation nomogram in an Asian population. Retrospective cross-sectional audit studies were conducted from March 2009 to March 2010. The use of a 10mg-loading dose to initiate warfarin treatment resulted in 33(84.6%) patients attaining a therapeutic INR within four days (mean time, 2.6 days). There was no significant correlation between age, gender, race, and serum albumin for the time to reach a therapeutic INR. A significant correlation was noted for patient's baseline INR and time to reach a therapeutic INR (P<0.05). No significant differences were observed in time to reach a therapeutic INR in patients treated with specific class of concomitant drugs or patients with specific disease states. The overall incidence of over-anticoagulation was 35.9%; however, no bleeding episodes were encountered. In conclusion, the use of a 10mg warfarin nomogram was effective in rapidly achieving a therapeutic INR. However, the nomogram's safety is debatable owing to the high over-anticoagulation rate warfarin-administered patients. Caution is recommended in the initiation of warfarin treatment using the 10mg nomogram.

AB - Anticoagulant responses to warfarin vary among patients, based on genetic factors, diet, concomitant medications, and disease state. We evaluated the effectiveness and safety of a 10mg warfarin initiation nomogram in an Asian population. Retrospective cross-sectional audit studies were conducted from March 2009 to March 2010. The use of a 10mg-loading dose to initiate warfarin treatment resulted in 33(84.6%) patients attaining a therapeutic INR within four days (mean time, 2.6 days). There was no significant correlation between age, gender, race, and serum albumin for the time to reach a therapeutic INR. A significant correlation was noted for patient's baseline INR and time to reach a therapeutic INR (P<0.05). No significant differences were observed in time to reach a therapeutic INR in patients treated with specific class of concomitant drugs or patients with specific disease states. The overall incidence of over-anticoagulation was 35.9%; however, no bleeding episodes were encountered. In conclusion, the use of a 10mg warfarin nomogram was effective in rapidly achieving a therapeutic INR. However, the nomogram's safety is debatable owing to the high over-anticoagulation rate warfarin-administered patients. Caution is recommended in the initiation of warfarin treatment using the 10mg nomogram.

KW - Anti-coagulation

KW - Coagulation

KW - INR

KW - Nomogram

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=84929176737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929176737&partnerID=8YFLogxK

M3 - Article

C2 - 26004726

AN - SCOPUS:84929176737

VL - 28

SP - 927

EP - 932

JO - Pakistan Journal of Pharmaceutical Sciences

JF - Pakistan Journal of Pharmaceutical Sciences

SN - 1011-601X

IS - 3

ER -